Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
investing
3
×
life sciences
national blog main
san francisco blog main
venture capital
boston
deals
diabetes
fda
indiana blog main
medical devices
national top stories
new york blog main
novartis
raleigh-durham blog main
roche
san diego blog main
san francisco top stories
seattle blog main
type 1 diabetes
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
arrowmark partners
autoimmune diseases
axitinib
bellus health
What
patients
3
×
million
startup
advantages
analytics
bar
beta
bio
biofourmis
bionics
blood
brings
closed
data
developing
device
devices
diabetes
digital
driven
drug
employs
expect
gamble
globally
hauls
heads
help
key
levels
manages
market
medco’s
medical
monitors
mover
new
pancreas
payers
physicians
Language
unset
Current search:
investing
×
patients
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
